Evaluation of the effects of flunixin meglumine, ketoprofen and phenylbutazone administration on the brain, renal and hepatic functions in Iranian cross-breed goats

Journal of Biological Sciences

Volumn 10, Issue 2, 2010, Pages 170-173

  Safarchi, R ^a   Mozaffari, A A ^b   Derakhshanfar, A ^b   Amiri Marvili, O ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b SHAHID BAHONAR UNIVERSITY OF KERMAN   (Iran)

Author keywords

Adverse effects; Flunixin meglumine; Goat; Ketoprofen; Phenylbutazone

Indexed keywords

ALBUMIN; FLUNIXIN MEGLUMINE; KETOPROFEN; PHENYLBUTAZONE; PROTEIN;

ANIMAL EXPERIMENT; ANOREXIA; ARTICLE; BLOOD SAMPLING; BRAIN FUNCTION; CONTROLLED STUDY; CROSS BREEDING; DIARRHEA; DRUG EFFECT; ENZYME ACTIVITY; ERYTHROCYTE COUNT; GOAT; HEMATOCRIT; HISTOPATHOLOGY; IRAN; KIDNEY FUNCTION; LEUKOCYTE DIFFERENTIAL COUNT; LIVER FUNCTION; MALE; NONHUMAN; URINALYSIS;

CAPRA HIRCUS;

EID: 77749251869     PISSN: 17273048     EISSN: 18125719     Source Type: Journal    
DOI: 10.3923/jbs.2010.170.173     Document Type: Article

References (22)

1. Burrows, G.E., 1981. Therapeutic effect of phenylbutazone on experimental acute Escherichia coli endotoxemia in ponies. Am. J. Vet. Res., 42: 94-99.
2. Carmichael, J. and S.W. Shankel, 1985. Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function. Am. J. Med., 78: 992-1000.
3. Clive, D.M. and J.S. Stoff, 1984. Medical progress: Renal syndromes associated with NSAID. N. Engl. J. Med., 310: 563-572.
4. Dunkle, N.J., G.D. Bottoms, J.F. Fessler, K. Knox and O.F. Roesel, 1985. Effects of flunixin meglumine on blood pressure and fluid compartment volume changes in ponies given endotoxin. Am. J. Vet. Res., 46: 1540-1544.
5. Gunson, D.E., 1983. Renal papillary necrosis in horses. J. Am. Vet. Med. Assoc, 182: 263-266.
6. Houdeshell, J.W. and P.W. Hennssey, 1977. A new non-steroidal, anti-inflammatory analgesic for horses. J. Equine. Med. Surg., 1: 57-63.
7. Insel, P.A., 1990. Analgesic-Antipyretics and Anti-Inflammatory Agents, Drugs Employed in the Treatment of Rheumatoid Arthritis and Gout. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics, Goodman, L.S. and A. Gilman (Eds.). Pergamon Press, New York, pp: 638-681.
8. Kari, F., J. Bucher, J. Haseman, S. Eustis and J. Huff, 1995. Long-term exposure to the anti-inflammatory agent phenylbutazone induces kidney tumors in rats and liver tumors in mice. Jap. J. Cancer Res., 86: 252-263.
9. Konigsson, K., K. Torneke, I.V. Engeland, K. Odensvik and H. Kindahl, 2003. Pharmacokinetics and pharmacodynamic effects of flunixin after intravenous, intramuscular and oral administration to dairy goats. Acta Vet. Scand., 44: 153-159.
10. Lees, P. and A.J. Higgins, 1987. Physiological, biochemical and haematological effects on horses of a phenylbutazone paste. Vet. Rec., 121: 56-60.
11. MacAlhster, C.G., S.J. Morgan, A.T. Borne and R.A. Pollet, 1993. Comparison of adverse effects of phenylbutazone, flunixin meglumine and ketoprofen in horses. J. Am. Vet. Med. Assoc., 202: 71-77.
12. Manoukian, A.V. and J.L. Carson, 1996. Nonsteroidal anti-inflammatory drug-induced hepatic disorders: Incidence and prevention. Drug Saf., 15: 64-71.
13. Meschter, C.L., M. Gilbert, L. Krook, G. Maylin and R. Corradino, 1990. The effects of phenylbutazone on the intestinal mucosa of the horse: A morphological, ultrastructural and biochemical study. Equine. Vet. J., 22: 255-263.
14. Mizuno, H., R.F. Liang and A. Kawabata, 1990. Effects of oral administration of various non-steroidal anti-inflammatory drugs on bone growth and bone wound healing in mice. Meikai. Daigaku. Shigaku. Zasshi., 19: 234-250.
15. Moore, J.N., M.M. Hardee and G.E. Hardee, 1986. Modulation of arachidonic acid metabolism in endotoxic horses: Comparison of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor. Am. J. Vet. Res., 47: 110-113.
16. Petrie, A. and P. Watson, 2006. Statistics for Veterinary and Animal Science. 2nd Edn., Blackwell Publishing, New York, ISBN: 1-4051-2781-3, pp: 95-104.
17. Read, W.K., 1983. Renal medullary crest necrosis associated with phenylbutazone therapy in horses. Vet. Pathol., 20: 662-669.
18. Snow, D.H., J. A. Bogan, T.A. Douglas and H. Thompson, 1979. Phenylbutazone toxicity in ponies. Vet. Rec., 105: 26-30.
19. Tietz, N.W., E.L. Prude and O. Sirgard-Anders on, 1994. Tietz Textbook of Clinical Chemistry. 2nd Edn., W. B. Saunders Company, London, ISBN: 0721656102, pp: 1354-1374.
20. Tobin, T. and S. Chay, 1986. Phenylbutazone in the horse: A review. J. Vet. Pharmacol. Ther., 9: 1-25.
21. Traub, D.J.L., J.J. Bertone, D.H. Gould, R.H. Wrigley, M.G. Weiser and S.D. Forney, 1988. Chronic flunixin meglumine therapy in foals. Am. J. Vet. Res., 49: 7-12.
22. Welsh, E.M., Q.A. McKellar and A.M. Nolan, 1993. The pharmacokinetics of flunixin meglumine in the sheep. J. Vet. Pharmacol. Ther., 16: 181-188.